China Shineway Pharmaceutical: no changes to share capital in November

China Shineway Pharmaceutical Group Limited, listed on the Hong Kong Stock Exchange under stock code 02877, filed its monthly return on movements in securities for the period ended November 30, 2025. The report, submitted on December 1, 2025, indicates no changes in the company's authorized, registered, or issued share capital during the month.

The company's authorized and registered share capital remains at 5,000,000,000 ordinary shares, each with a par value of HK$0.1, totaling HK$500,000,000. The total number of issued shares (excluding treasury shares) stood at 827,000,000 as of the end of November 2025, with no reported increase or decrease from the preceding month. The company also confirmed no treasury shares were held.

This monthly submission reaffirms that all conditions related to the company's issued securities comply with applicable listing rules, regulatory requirements, and legal provisions, with all necessary documents filed and funds received. The report highlighted the absence of movements in share options, warrants, convertibles, or other agreements to issue shares.